Merck & Co. Animal Health
MRK · New York Stock Exchange · Health Care
Shareholder advocacy aimed at Merck & Co. Animal Health
1 recorded campaign from 1 organization.
Coordinates an Animal Pharmaceuticals engagement with the largest listed veterinary-drug makers on antimicrobial resistance
Investor coalition presses seven of the largest publicly-listed animal-pharma companies for transparency on antibiotic manufacturing/marketing/sales and antimicrobial-resistance risk management. Progress report "From Farms to Forks" published May 2024; investor guide co-developed with MSCI Sustainability Institute and IAAMR in 2024.
What shareholders voted on
From Merck & Co. Animal Health’s own filings with the SEC. Support is the share of votes cast for and against, so abstentions and broker non-votes are not counted in it.
2026
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| Stephen L. Mayo, Ph.D. | Company proposal | 99.7% | Passed | |
| Christine E. Seidman, M.D. | Company proposal | 99.6% | Passed | |
| Risa J. Lavizzo-Mourey, M.D. | Company proposal | 99.1% | Passed | |
| Paul B. Rothman, M.D. | Company proposal | 99% | Passed | |
| Election of Douglas M. Baker, Jr. | Director | 99.7% | Passed | |
| Election of Mary Ellen Coe | Director | 99.2% | Passed | |
| Election of Surendralal L. Karsanbhai | Director | 98.9% | Passed | |
| Election of Inge G. Thulin | Director | 98.3% | Passed | |
| Election of Kathy J. Warden | Director | 98.2% | Passed | |
| Election of Pamela J. Craig | Director | 97.4% | Passed | |
| Election of Robert M. Davis | Director | 93.6% | Passed | |
| Election of Thomas H. Glocer | Director | 93.4% | Passed | |
| Election of Patricia F. Russo | Director | 88.3% | Passed |
2025
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| Stephen L. Mayo, Ph.D. | Company proposal | 99.7% | Passed | |
| Christine E. Seidman, M.D. | Company proposal | 99.6% | Passed | |
| Paul B. Rothman, M.D. | Company proposal | 99.5% | Passed | |
| Risa J. Lavizzo-Mourey, M.D. | Company proposal | 98.8% | Passed | |
| Election of Douglas M. Baker, Jr. | Director | 99.7% | Passed | |
| Election of Surendralal L. Karsanbhai | Director | 99.6% | Passed | |
| Election of Mary Ellen Coe | Director | 98.9% | Passed | |
| Election of Pamela J. Craig | Director | 98.1% | Passed | |
| Election of Inge G. Thulin | Director | 97.8% | Passed | |
| Election of Kathy J. Warden | Director | 97.3% | Passed | |
| Election of Thomas H. Glocer | Director | 92.6% | Passed | |
| Election of Robert M. Davis | Director | 91.5% | Passed | |
| Election of Patricia F. Russo | Director | 86.4% | Passed |
2024
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| Stephen L. Mayo, Ph.D. | Company proposal | 99.5% | Passed | |
| Christine E. Seidman, M.D. | Company proposal | 99.4% | Passed | |
| Paul B. Rothman, M.D. | Company proposal | 99.3% | Passed | |
| Risa J. Lavizzo-Mourey, M.D. | Company proposal | 98.7% | Passed | |
| Election of Mary Ellen Coe | Director | 98.8% | Passed | |
| Election of Douglas M. Baker, Jr. | Director | 97.8% | Passed | |
| Election of Pamela J. Craig | Director | 97.7% | Passed | |
| Election of Kathy J. Warden | Director | 97.1% | Passed | |
| Election of Inge G. Thulin | Director | 97.1% | Passed | |
| Election of Thomas H. Glocer | Director | 91.9% | Passed | |
| Election of Robert M. Davis | Director | 91.7% | Passed | |
| Election of Patricia F. Russo | Director | 84.8% | Passed |
2023
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| Paul B. Rothman, M.D. | Company proposal | 99.4% | Passed | |
| Stephen L. Mayo, Ph.D. | Company proposal | 99.4% | Passed | |
| Christine E. Seidman, M.D. | Company proposal | 99.3% | Passed | |
| Risa J. Lavizzo-Mourey, M.D. | Company proposal | 97.4% | Passed | |
| Election of Mary Ellen Coe | Director | 98.2% | Passed | |
| Election of Douglas M. Baker, Jr. | Director | 98.2% | Passed | |
| Election of Pamela J. Craig | Director | 97.9% | Passed | |
| Election of Kathy J. Warden | Director | 97.8% | Passed | |
| Election of Inge G. Thulin | Director | 97% | Passed | |
| Election of Peter C. Wendell | Director | 95.6% | Passed | |
| Election of Thomas H. Glocer | Director | 92.6% | Passed | |
| Election of Robert M. Davis | Director | 91.5% | Passed | |
| Election of Patricia F. Russo | Director | 86.1% | Passed |
2022
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| Christine E. Seidman, M.D. | Company proposal | 99.6% | Passed | |
| Paul B. Rothman, M.D. | Company proposal | 99.6% | Passed | |
| Stephen L. Mayo, Ph.D. | Company proposal | 99.6% | Passed | |
| Risa J. Lavizzo-Mourey, M.D. | Company proposal | 98.2% | Passed | |
| Election of Mary Ellen Coe | Director | 99.6% | Passed | |
| Election of Douglas M. Baker, Jr. | Director | 99.6% | Passed | |
| Election of Kathy J. Warden | Director | 99.4% | Passed | |
| Election of Robert M. Davis | Director | 99.3% | Passed | |
| Election of Inge G. Thulin | Director | 99% | Passed | |
| Election of Kenneth C. Frazier | Director | 96.9% | Passed | |
| Election of Peter C. Wendell | Director | 95.6% | Passed | |
| Election of Thomas H. Glocer | Director | 95% | Passed | |
| Election of Pamela J. Craig | Director | 94.7% | Passed | |
| Election of Patricia F. Russo | Director | 86% | Passed |
2021
2020
2019
2018
| Item | Kind | Asked for by | Support | Outcome |
|---|---|---|---|---|
| A shareholder proposal concerning shareholders' right to act by written consent received the following votes | Shareholder proposal | 44.9% | Failed | |
| A proposal to approve, by non-binding advisory vote, the compensation of our Named Executive Officers received the following votes | Say on pay | 94.6% | Passed | |
| A proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2018 received the following votes | Auditor | 98.4% | Passed | |
| Election of Pamela J. Craig | Director | 99% | Passed | |
| Election of Peter C. Wendell | Director | 98.9% | Passed | |
| Election of Rochelle B. Lazarus | Director | 98.2% | Passed | |
| Election of Thomas H. Glocer | Director | 98% | Passed | |
| Election of Kenneth C. Frazier | Director | 96.3% | Passed | |
| Election of Patricia F. Russo | Director | 95.5% | Passed | |
| Election of Leslie A. Brun | Director | 94.7% | Passed | |
| Election of Inge G. Thulin | Director | 93% | Passed | |
| Election of Wendell P. Weeks | Director | 86% | Passed |
Proxy statements and vote results
Straight from Merck & Co. Animal Health’s own SEC filings. The proxy statement lists what shareholders were asked to vote on; the 8-K certifies how the vote went.
| Year | Filing | Filed |
|---|---|---|
| 2026 | Vote results | 2026-05-28 |
| 2026 | Proxy statement | 2026-04-08 |
| 2025 | Vote results | 2025-05-29 |
| 2025 | Proxy statement | 2025-04-09 |
| 2024 | Vote results | 2024-05-30 |
| 2024 | Proxy statement | 2024-04-11 |
| 2023 | Vote results | 2023-05-26 |
| 2023 | Proxy statement | 2023-04-03 |
| 2022 | Vote results | 2022-05-26 |
| 2022 | Proxy statement | 2022-04-04 |
| 2021 | Vote results | 2021-05-27 |
| 2021 | Proxy statement | 2021-04-05 |
| 2020 | Vote results | 2020-05-29 |
| 2020 | Proxy statement | 2020-04-06 |
| 2019 | Vote results | 2019-05-31 |
| 2019 | Proxy statement | 2019-04-08 |
| 2018 | Vote results | 2018-05-24 |
| 2018 | Proxy statement | 2018-04-09 |
Do you represent Merck & Co. Animal Health? Claim this profile to respond to the campaigns listed here.
